Rejuvesol
NDC 23731-7000, Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate, solution, from Citra Labs, LLC.
- Product NDC
- 23731-7000
- Status
- Listed
- Labeler
- Citra Labs, LLC
- Dosage form
- SOLUTION
- Route
- EXTRACORPOREAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- BN950522
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/23731-7000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM PYRUVATE.55 g/50mL
- INOSINE1.34 g/50mL
- ADENINE.034 g/50mL
- SODIUM PHOSPHATE, DIBASIC.73 g/50mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE.311 g/50mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 23731-7000-5 | 23731700005 | 12 VIAL, SINGLE-USE in 1 CASE (23731-7000-5) / 50 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/bc06c40f-81a0-45e5-80b6-61f67d445068
Use it
Look up 23731-7000 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/23731-7000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 23731-7000. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.